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Chapter 3
Anticoagulant Rodenticide Toxicity  
to Non- target Wildlife Under Controlled 
Exposure Conditions
Barnett A. Rattner and F. Nicholas Mastrota
1  Introduction
Our knowledge of the toxicity of anticoagulant rodenticides (ARs) can be traced to 
investigations of Karl Paul Link and colleagues on “bleeding disease” in cattle, the 
eventual isolation of dicoumarol from moldy sweet clover, synthesis of this causative 
agent, and its application as a therapeutic anticoagulant in clinical medicine in 1941 
(Link 1959). The notion of a coumarin-based rodenticide as a better “mouse-trap” 
occurred to Link in 1945 while reviewing laboratory chemical and bioassay data. By 
1948, the highly potent compound number 42, warfarin, was promoted as a rodenti-
cide (Link 1959; Last 2002). Through laboratory studies and clinical use of warfarin 
(Coumadin), a detailed understanding of the mechanism of action and toxicity of 
warfarin and related ARs (Fig. 3.1) unfolded in the decades that followed.
Our understanding of AR toxicity has been principally derived from an array of 
biochemical through whole animal studies. Structure-activity relationship models 
indicate that AR potency (i.e., toxicity in rodents) is related to the length and hydro-
phobicity of the side chain in the vicinity of carbon 13 (Fig. 3.2), with the most 
active compounds having greater volume and bulky lipophilic groups in this activity 
domain (Thijssen 1995; Domella et al. 1999). At the molecular level, both coumadin- 
and indandione-based ARs inactivate vitamin K epoxide reductase (VKOR), a 
membrane protein present in the endoplasmic reticulum of liver and other tissues. 
Catalytic activity of VKOR is required for the reduction of vitamin K epoxide and 
vitamin K to form vitamin K hydroquinone (Fig.  3.3). This biologically-active 
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hydroquinone is required for γ-glutamyl carboxylation of clotting factors. Inhibition 
of VKOR by ARs limits the formation of vitamin K hydroquinone resulting in 
under-carboxylation of clotting factors II, VII, IX and X (Furie et al. 1999) that 
do not assemble on cell surfaces to form a clot. It is believed that ARs bind tightly 
to the proposed warfarin-binding site of VKOR at tyrosine residue 135  in close 
proximity to the active site (cysteines 132 and 135) of this 163 amino acid enzyme 
(Tie and Stafford 2008). Notably, some point mutations can impede AR binding and 
thus confer resistance in target pest species (Boyle 1960; Pelz et al. 2005).
Once the fully-functional clotting factors are cleared from the blood, the des-γ 
carboxyl dysfunctional clotting factors no longer support hemostasis. Hemorrhage 
may ensue spontaneously or can be triggered by traumatic events. Coagulopathy 
may be accompanied by anemia, hypovolemic shock, altered tissue perfusion, organ 
Fig. 3.1 Class, compound, Chemical Abstracts Service Number and structure of 12 anticoagulant 
rodenticides (From: https://www.ncbi.nlm.nih.gov/pccompound)
First-generation hydroxycoumarins
Warfarin
81-81-2
Coumachlor
81-82-3
Coumafuryl
117-52-2
Coumatetr
5836-29-3
alyl
Intermediate-generation indandiones
Chlorophacinone
3691-35-8
Diphacinone
82-66-6
Pindone
83-26-1
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dysfunction, and necrosis. Overt signs of intoxication include bruising, bleeding, 
blood in droppings and urine, pallor, and other signs not specific to coagulopathy 
(e.g., asthenia, ataraxia, labored breathing, immobility). The proximate cause of 
death may seemingly be unrelated to AR poisoning, but in fact ultimately triggered 
by AR-residues and coagulopathy. In addition to impaired blood clotting, some ARs 
have been shown to increase membrane permeability, affect other vitamin 
K-dependent proteins, growth factors, and signal transduction (reviewed in Rattner 
et al. 2014a). Notably, large doses of indandiones can cause toxicity and result in 
death independent of coagulopathy (Kabat et  al. 1944), probably by impairing 
cellular energy generation through the uncoupling of  oxidative phosphorylation 
Second-generation hydroxycoumarins
Brodifacoum
56073-10-0
Bromadiolone
28772-56-7
Difenacoum
56073-07-5
Difethialone
104653-34-1
Flocoumafen
90035-08-8
Fig. 3.1 (continued)
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Fig. 3.2 Structure of the first-generation anticoagulant rodenticides warfarin and diphacinone, 
and the second- generation anticoagulant rodenticide brodifacoum, illustrating side chains (red) of 
the activity domain (*) in vicinity of carbon 13 (Modified with permission from Rattner et  al. 
2014a, Copyright 2015 American Chemical Society) (Color figure online)
Fig. 3.3 Vitamin K cycle illustrating anticoagulant rodenticide (AR) sensitive vitamin K epoxide 
reductase (VKOR) reactions and a warfarin-insensitive VKOR that reduces vitamin K to the 
biologically- active vitamin K hydroquinone. Without adequate vitamin K hydroquinone, 
γ-glutamyl carboxylase (critical reaction circled in green) lacks substrate to adequately carboxyl-
ate clotting factors II, VII, IX and X (Reprinted with permission from Rattner et  al. 2014a, 
Copyright 2015 American Chemical Society)
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(van den Berg and Nauta 1975). Numerous controlled exposure studies have docu-
mented in vitro biochemical effects, and in vivo physiological, pharmacological and 
whole organism responses in domesticated species and to a lesser degree captive 
wildlife (reviewed in IPCS 1995; Joermann 1998; Rattner et al. 2014a), and much 
is known from clinical use and accidental poisoning incidents in humans (Watt et al. 
2005). Recently, a proposed adverse outcome pathway, identifying the molecular 
 initiating/anchoring event, and established and plausible linkages associated with 
toxicity through individual and even population levels, has been developed for non-
target predatory birds and mammals (Fig. 3.4) (Rattner et al. 2014a)
The use of vertebrate pesticides, and specifically ARs, requires detailed toxico-
logical knowledge and regulatory evaluation to ensure a compound does not pose an 
unacceptable risk to non-target biota and the environment (Eason et al. 2010). The 
review and approval process takes into account economic, social and environmental 
costs and benefits (Eason et al. 2010). An integral component of this process is the 
generation of toxicity data for non-target wildlife. These data are used to examine 
the potential hazard and risk associated with direct bait ingestion and consumption 
of AR-exposed prey by non-target species. For purposes of AR registration, much of 
these data are generated using standardized toxicity testing methods. However, 
additional research on AR absorption, distribution, metabolism, pharmacokinetics 
and underlying mechanism of action is often undertaken to more fully evaluate and 
explain interspecific differences in toxicity. The generation of these data usually 
entails in vivo testing in species maintained in captivity using various exposure 
scenarios. This chapter will principally focus on data generated from such studies in 
terrestrial wildlife (mammals, birds and reptiles) or domesticated surrogate species 
used to predict effects in non-target wildlife.
1.1  Standardized Tests, Their Limitations and Implications
As terrestrial wildlife may be exposed by direct consumption of AR-containing 
bait and/or by predation or scavenging on exposed or poisoned rodents, standard-
ized tests have focused on the dietary route of exposure. Notably, exposure path-
ways have yet to be clearly elucidated for aquatic species. Standardized testing 
protocols allow regulators to compare the toxicities of various chemicals to ter-
restrial wildlife and examine the range of species sensitivities to a particular 
chemical. In the wildlife- pesticide regulatory arena, the most commonly used 
endpoint for toxicity is mortality because of its definitive nature. The two most 
commonly conducted standardized tests for lethality are the single-dose acute 
oral toxicity test that is used to generate a median lethal dose (LD50) and the 
5-day subacute dietary toxicity test that generates a median lethal dietary con-
centration (LC50). Other endpoints may be monitored during such tests (overt 
signs of intoxication, food consumption, body weight change, and evidence of 
pathological lesions). The fixed dose procedure, acute toxic class method, up–
and-down procedure, and sequential testing schemes have been developed that 
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permit estimation of various parameters (e.g., limit dose, median lethal dose, 
slope of dose-response curve) with greatly reduced numbers of test subjects 
(reviewed in Andrew 2014; OECD 2010). The most commonly tested species 
include the mallard (Anas platyrhynchos) and bobwhite (Colinus virginianus) 
that are available from game farms as a model avian species (note: used out of 
convenience rather than likelihood of AR exposure), and common strains of 
domesticated laboratory mice (Mus musculus) and rats (Ratus norvegicus) that 
are used as surrogates for wild mammals. While the focus of this chapter is on 
non-target species, it is worth noting that a great deal of effort has been devoted 
to the development of tests and data addressing the efficacy of ARs on target spe-
cies (e.g., Prescott and Johnson 2015).
The acute oral toxicity test generally entails administration of a single dose of 
the test compound by gavage or in a capsule, followed by a 14-day observation 
period. Acute oral exposure may also involve repeated dosing within a 24-h period 
to achieve sufficient exposure for compounds of low acute toxicity. The 5-day 
subacute dietary toxicity test entails ad libitum exposure of animals to feed 
amended with the test compound for 5 days followed by an untreated diet for 3 
days. In both the acute oral and subacute dietary tests, the post-exposure observa-
tion period can be lengthened (e.g., 21, 25 or 30 days post-exposure) to detect 
latent effects, which are often seen with ARs. The LD50 and LC50 values, their 
95% confidence intervals, and slopes are used as indices to compare toxicity 
among different compounds and species (Klaassen 1986; Hill 1994). These mea-
sures of toxicity have application for assessing the hazards of direct ingestion of 
AR bait, and when tissue residue data are available or modeled, they can be used 
to assess the potential hazard of ingestion of poisoned prey by non-target preda-
tory wildlife. While standardized test methods are used in chemical registration 
and in research, their application in risk assessments without regard to the expo-
sure regimen and mode of action can sometimes be misleading, and even result in 
a false sense of safety. This is especially true when examining and comparing 
acute oral toxicity data for the first-generation and indandione ARs to second-
generation compounds, and will be discussed in detail later in this chapter. 
Another challenging aspect of AR toxicity studies is that mortality may be 
delayed for days to weeks after termination of AR exposure, seemingly because 
VKOR activity may remain partially inhibited, and thus render an individual more 
vulnerable to the effects of subsequent exposure and/or trauma for an extended 
period of time (e.g., Mosterd and Thijssen 1991).
Less standardized are secondary exposure tests in which predatory or scavenging 
birds and mammals are provided whole or ground carcasses of AR-exposed rats or 
mice, or meat amended with ARs. As reviewed by Joermann (1998) and the USEPA 
(2004), numerous studies have examined the hazard of first-generation ARs (FGARs; 
e.g., warfarin, coumachlor, coumafuryl, coumatetralyl),  intermediate- generation 
indandione ARs (e.g., chlorophacinone, diphacinone, pindone; often classified as 
FGARs), and second-generation ARs (SGARs; e.g., brodifacoum, bromadiolone, dif-
enacoum, difethialone, flocoumafen) in predators. It is noteworthy that the exposure 
duration in such studies has been highly variable, ranging from 1 to 90 days; mortal-
ity, rather than sublethal effects, has been the principal measurement endpoint.
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It has long been acknowledged that there are inherent differences among domes-
ticated and captive species compared to free-ranging animals that encounter nutri-
tional, temperature, disease, injury and other chemical stressors that may alter 
sensitivity to ARs (Vyas et al. 2006). There are key issues and even deficiencies in 
controlled exposure studies which may limit the extrapolation of results to wild 
animals. For example, test conditions are artificial, generally entailing no-choice ad 
libitum feeding scenarios, which limit social interactions and physical trauma asso-
ciated with foraging in free-ranging animals that could trigger bleeding events. 
Such factors may affect the spontaneous nature of hemorrhage in AR-exposed ani-
mals, which seems to be a “multi-causative phenomena” affected by stress and other 
variables (Kaukeinen 1982). While such interacting factors are acknowledged, the 
extrapolation of toxicity thresholds and lethality estimates derived from controlled 
exposure studies have been of value in both forensic evaluations and in assessing 
risk of ARs to non-target wildlife.
2  Acute Oral Toxicity Studies
Table 3.1 is a compilation of the reported acute oral LD50 estimates (single dose 
studies) for 12 ARs in common laboratory test species (mammal: laboratory rat in 
column 2; bird: bobwhite, Japanese quail (Coturnix japonica) and mallard in col-
umn 4). Data for these species were principally derived from pesticide registration 
or re-registration submissions that have been compiled and summarized in formal 
reviews by the U.S. Environmental Protection Agency (USEPA 1998, 2004, 2011), 
or described in other criteria documents (International Programme on Chemical 
Safety 1995; McLoed and Saunders 2013). For most of these compounds, the test 
methods have been critiqued and the results often statistically re-evaluated by reg-
ulatory agencies to insure quality and comparability for use in ecological risk 
assessments. Data sets for some of the older compounds were generated with fewer 
test subjects and dose levels than currently required. Furthermore, many com-
pounds exhibit shallow dose-response curves making estimates of LD50s chal-
lenging, with 95% confidence interval and slope estimates not being available or 
robust for many ARs. With all of these caveats in mind, here are some of the high-
lights from common test species that include the laboratory rat, bobwhite, Japanese 
quail and mallard:
 1. Using an acute oral (single or multiple doses within a 24 h period) exposure regi-
men, SGARs are more toxic (potent) than FGARs.
 2. It is noteworthy that the range (i.e., extremes) of LD50 estimates for an AR in a 
given species can be substantial. Notably, there are differences in AR sensitivity 
among outbred strains of commonly-tested laboratory rats, with LD50 estimates 
varying by twofold (Ashton et al. 1986) to orders of magnitude (Jackson and 
Ashton 1992; USEPA 2004). For example, the reported LD50s in laboratory rats 
for warfarin range from 2.5 to 680 mg/kg body weight (USEPA 2004).
B.A. Rattner and F.N. Mastrota
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 3. Median lethal dose estimates for most ARs appear to be one to two orders of 
magnitude lower (i.e., more toxic or potent) in laboratory rats than in commonly 
tested avian species. Notable exceptions include the SGARs brodifacoum and 
difethialone for which LD50 values are quite comparable between these mam-
malian and avian species.
In addition, Table  3.1 also contains LD50 estimates, range and limit data for 
other domesticated and wild birds and mammals. Here are some conclusions that 
can be drawn from comparisons of toxicity findings among species:
 1. For a given AR, order of magnitude differences are apparent among various 
species of mammals.
 2. Apparent differences in species sensitivity are inconsistent among compounds. 
For example, domestic cats seem to be more sensitive to warfarin than domestic 
dogs, while the opposite seems to be the case for brodifacoum, difenacoum and 
flocoumafen.
 3. There are limited data on the acute oral toxicity of ARs for avian species other 
than bobwhite, Japanese quail and mallards. While brodifacoum has been tested 
in many other species of birds (Godfrey 1985; McLoed and Saunders 2013), the 
toxicity estimates may not be robust as most of the species were wild-caught, no 
control birds were used, some species had high levels of lead in liver, and some 
individuals were reported as not eating and sustaining injuries (capture stress).
 4. There is some evidence that the American kestrel is 15–20 times more sensitive to 
diphacinone than common avian test species, as rigorous studies were conducted 
for these species by the same group of investigators (Rattner et al. 2010, 2011).
Remarkable gender differences in the LD50 dose of warfarin have been noted, 
with female rats being nearly an order of magnitude more sensitive than males 
(Hagan and Radmonski 1953). This observation is not uniform among ARs 
(USEPA 1998), and some studies suggest that male rats and mice seem to be more 
sensitive to difenacoum than females (Winn et al. 1987). While not the objective of 
this chapter, a major research effort entailing controlled exposure studies has char-
acterized the development, magnitude and genetic basis of resistance to first- and 
second-generation ARs in “target” Norway rats and other rodents (e.g., Greaves and 
Cullen-Aryes 1988; Thijssen 1995; Pelz et al. 2005; Prescott et al. 2007; Buckle 
2013). The issue of differential sensitivity between sexes extends into the realm of 
genetically-based AR resistance (Pelz et  al. 2005; Berny 2011), with resistant- 
female rodents often exhibiting greater tolerance than resistant-males (e.g., Wallace 
and MacSwiney 1976; Thijssen 1995). In contrast to rodents, potential effects of sex 
and resistance on AR toxicity have not been thoroughly examined in birds and lower 
vertebrates.
While the potential hazards of ARs to reptiles have been discussed in many 
reviews (e.g., Pauli et al. 2010), to our knowledge only three studies have generated 
acute toxicity data from which a median lethal dose could be estimated. The acute 
oral toxicity of warfarin and diphacinone was studied in the brown tree snake (Boiga 
irregularis) (Brooks et al. 1998). From the data presented, the LD50 for diphacinone 
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is estimated to be 32.2 mg/kg, while the limited dataset for warfarin suggested that 
lethality occurred at 20 and 40 mg/kg when ethanol was used as a vehicle. Notably, 
neither warfarin nor diphacinone evoked hemorrhage or other signs of intoxication in 
the brown tree snakes that is typically found in AR-intoxicated higher vertebrates. 
Incidentally, dermal exposure to diphacinone (40 mg/kg) using ethanol as a vehicle 
did not evoke toxicity. In highly detailed studies, Weir et  al. (2015) reported that 
brodifacoum administered orally (capsule) or applied dermally (neat material placed 
on dorsal surface and covered with an occlusive bandage) to Western fence lizards 
(Sceloporus occidentalis) did not evoke signs of intoxication at doses ranging up to 
1750 mg/kg. Using similar methods, the acute oral median lethal dose for coumate-
tralyl exceeded 1750 mg/kg, for diphacinone the LD50 was ~1750 mg/kg, and for 
pindone the LD50 was estimated to be 550 mg/kg (Weir et al. 2016). Thus, the LD50s 
for coumatetralyl, diphacinone, pindone and brodifacoum in Western fence lizards 
exceeded laboratory rodent values by one to two orders of magnitude.
2.1  Single-Day Versus Multi-Day Exposures on AR Toxicity
The older first-generation hydroxycoumarin and indandione ARs require multiple 
daily bait feedings to kill target pest species, while the newer SGARs, with longer 
tissue half-lives, may only require a single feeding to kill pest species. However, the 
toxicity of FGARs may be greatly enhanced when administered repeatedly. 
Specifically, FGARs administered for 5 consecutive days to laboratory rats yield 
lower cumulative dose LD50 estimates (i.e., more toxic or potent) than LD50 esti-
mates derived from single-day oral dose trials (Ashton et  al. 1986; Jackson and 
Ashton 1992). This trend is apparent when one uses the lowest LD50 estimates for 
laboratory rats presented in Table 3.1. For example, the 5-day cumulative exposure 
LD50 estimate for warfarin is 1.65 mg/kg (Ashton et al. 1986; Jackson and Ashton 
1992), while the single-day oral dose LD50 estimate is 2.5  mg/kg (Table  3.1). 
Likewise, the 5-day cumulative LD50 estimate for chlorophacinone is 0.95 mg/kg 
(Ashton et al. 1986; Jackson and Ashton 1992), while the single-day oral dose LD50 
estimate is 6.26 mg/kg (Table 3.1). Some comparisons even suggest order of mag-
nitude differences in lethality between cumulative dose from consecutive day expo-
sures versus a single oral dose exposure. For example, when diphacinone was 
administered in the diet of Eastern screech-owls (Megascops asio) for 7 days, the 
lowest lethal cumulative dose was 5.75 mg/kg, yet when administered as a single- 
day oral dose, the lowest lethal dose during the week long observation period was 
171.2 mg/kg (Rattner et al. 2012a, b). Toxicity tests employing multiple day expo-
sures may be more appropriate and environmentally relevant (i.e., multiple daily 
bait feedings are necessary to evoke death in target rodents) for assessing the risk of 
FGARs in non-target species (Vyas and Rattner 2012). Furthermore, comparatively 
greater potency of SGARs compared to FGARs is diminished when FGARs are 
administered on multiple days.
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3  Subacute Dietary Toxicity Studies
Table 3.2 presents the range of reported dietary LC50 estimates for 5 ARs in labora-
tory rats and 8 ARs in common avian test species (bobwhite and Japanese quail, 
mallard). There are apparently no standardized subacute dietary toxicity test data 
available for the FGARs coumachlor, coumafuryl, coumatetralyl or pindone. For 
the SGARs difenacoum, difethialone, and flocoumafen, only dietary exposure test 
data are available for avian species. For the FGARs warfarin, chlorophacinone and 
diphacinone, and the SGAR bromadiolone, LC50 estimates in birds are more than 
an order of magnitude greater (i.e., less toxic) than in laboratory rats. However, for 
the SGAR brodifacoum, LC50 estimates are rather comparable between birds and 
mammals, which is similar to the trend noted in the acute oral toxicity tests 
(Table 3.1).
Innumerable dietary exposure trials have assessed AR efficacy in target rodents 
and some other mammalian pest species. However, far fewer studies have examined 
AR lethality in non-target animals from direct consumption of AR bait. Although 
these non-target studies have not generated LC50 estimates, they do utilize realistic 
exposure scenarios with practical application. In a review by Mount and coauthors 
(1986), the minimum quantity of several ARs fed or administered over several days 
that could potentially be lethal in dogs was evaluated. For warfarin, 1–5 mg warfa-
rin/kg body weight for 5–15 days was found to be lethal. However, in a study with 
fox terriers, dogs succumb by ingesting warfarin bait at daily doses as low as 
0.19 mg/kg for 12 days (Prier and Derse 1962), which is considerably lower that 
reported by Mount and coworkers (1986). For indandiones, Mount et  al. (1986) 
estimated lowest lethal doses of 0.05 mg chlorophacinone/kg body weight adminis-
tered for 10 days, 0.16 mg diphacinone/kg body weight administered for 3 days, and 
15–35 mg pindone/kg body weight administered over several days. For SGARs, 
most studies in dogs have examined hazard by considering bait ingestion for a sin-
gle day. Lethality of brodifacoum in dogs was estimated to be as low as 0.25 mg/kg 
(Mount et al. 1986), which corresponds to 68 g of brodifacoum bait (0.005% ai) and 
others have suggested as few as 8 brodifacoum (Talon®) pellets (Mackintosh et al. 
1988). Bromadiolone lethality in dogs was estimated to be about 11–15 mg/kg body 
weight (Mount et  al. 1986), although a lowest-observed-adverse-effect-level has 
been estimated for 90 day exposures (i.e., 0.008 mg bromadiolone/kg body weight/
day; Bromadiolone Assessment Report 2010). The maximum tolerated dose of dife-
thialone bait (0.0025% ai) is estimated at 400 g of bait (Lechevin and Poche 1988), 
although it would appear that these data are for an acute exposure scenario.
The dietary toxicity of warfarin was assessed in a 28-day feeding trial in mink 
(Mustela vison), and yielded an LC50 estimate of 11.7 mg/kg feed, with overt signs 
of intoxication apparent at a dietary concentration of 7 mg/kg feed (Aulerich et al. 
1987). Oral sub-chronic toxicity studies in pigs (Sus scrofa) have documented mor-
tality in as few as 8 days for warfarin (5 mg/pig/day) and for brodifacoum in as few 
as 14 days (1 mg/pig/day), although details of the body weight of the pigs are not 
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readily available (Lechevin and Poché 1988). Toxicity data for warfarin for feral 
pigs fed warfarin baits for 3 days are in the order of 20 mg/kg body weight (Hone 
and Kleba 1984). Although not truly a dietary study, daily oral dosing with pindone 
for 3 days (decreasing from 10 to 3 to 2 mg/kg body weight) to simulate bait inges-
tion by merino sheep (Ovis aries), and even repeating this exposure regimen 8 days 
later, did not evoke mortality (Robinson et al. 2005). However, a subsequent trial 
found 11% mortality of pindone-exposed sheep due to excessive bleeding following 
shearing. A 5-day dietary difethialone exposure trial with European ferrets (Mustela 
putoris furo) found signs of intoxication, but dose-response characteristics did not 
permit estimation of an LC50 (>112 mg/kg food; USEPA 2004). A detailed study of 
behavioral toxicity of brodifacoum in the destructive vertebrate pest, the brushtail 
possum (Trichosurus vulpecula), revealed that ingestion of about 0.88 mg over a 3 
day period resulted in mortality of 16 of 18 individuals by day 50, with an average 
time to death of 20.7 days (Littin et al. 2002).
Dietary studies in which various species of birds (chukar, Alectoris chukar; 
Japanese quail; Leghorn chicks, Gallus domesticus) were fed warfarin for up to 30 
days at concentrations ranging up to those in bait products found little or no evi-
dence of toxicity (Crabtree and Robison 1952; Christopher et al. 1984). Lund (1981) 
provided laying domestic leghorn hens a choice of untreated diet or diet containing 
various ARs at concentrations corresponding to those found in some bait products 
(0.025% warfarin; 0.03% coumatetralyl; 0.005% brodifacoum, bromadiolone or 
difenacoum) for up to 15 days. While ingestion of warfarin did not affect hens, the 
FGAR coumatetralyl and all three SGARs evoked signs of intoxication or death 
within 6–14 days (Lund 1981). Notably, with chronic dietary exposure (up to 20 
weeks), mortality and other signs of intoxication have been reported in chickens fed 
warfarin at dietary concentrations of 25–100 ppm, which is less than levels in some 
Table 3.2 Subacute dietary toxicity values for commonly tested mammals and birds
Class Mammal Bird
Compound
LC50 (mg/kg diet) for 
Laboratory Rat
LC50 (mg/kg diet) for Bobwhite, 
Japanese Quail or Mallard
First-generation hydroxycoumarins
Warfarin 4.41–6.03 428–5000
Intermediate-generation indandiones
Chlorophacinone 1.13–1.27 55.8–426
Diphacinone 2.08–2.55 906–10,000
Second-generation hydroxycoumarins
Brodifacoum 0.53–0.84 1.33–2.75
Bromadiolone 0.92–1.98 37.6–464
Difenacoum NA 18.9–989
Difethialone NA 0.56–1.96
Flocoumafen NA 1.7
For some compounds, estimates are not available (NA) (Source documents: DEFRA 1987, USEPA 
1998, 2004, 2011)
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rodenticide bait products (Veltmann et al. 1981). When brodifacoum or bromadio-
lone baits diets were fed on alternate days to 3-week-old chicks for up to 21 days, 
signs of intoxication were observed in only 2 of 18 chicks fed bromadiolone, 
whereas brodifacoum evoked mortality in 12 of 18 exposed chicks (Christopher 
et al. 1984).
4  Toxicity Studies Involving Secondary Exposure
Two significant reviews have summarized controlled studies that examine AR expo-
sure and effects in predators and scavengers (i.e., secondary consumers) (Joermann 
1998; USEPA 2004), but few secondary exposure studies have been conducted 
since 2000. In the feeding trials described in these reviews and other documents, 
whole AR-exposed target rodents, tissue derived from exposed prey, or tissue from 
a prey surrogate were offered to predators using various exposure regimens. The 
prey used in most studies were target rodents (rats or mice), but some studies used 
other small mammals or birds. The studies generally exposed the prey to food con-
taining one or more concentrations of an AR that is registered for use in commercial 
rodent bait products. In most feeding trials, AR residues in whole prey or prey tissue 
were  estimated (but rarely analytically verified), thus making it challenging to fully 
characterize secondary exposure and risk to non-target birds and mammals. The 
most commonly used endpoints of exposed predators or scavengers include death 
and survival, overt signs of intoxication (e.g., hemorrhage, pallor, changes in behav-
ior, debilitation), gross pathology of animals which succumb (a few studies have 
examined histopathological lesions), and changes in blood clotting time as indica-
tors of adverse effects. Abbreviated findings of the secondary exposure studies are 
described in the sections that follow. A generalized summary of prey exposure and 
secondary consumer mortality is presented in Table 3.3.
4.1  Secondary Exposure Studies in Mammals
First-generation ARs As described by Erickson and Urban (USEPA 2004), second-
ary exposure studies in mammals consuming warfarin exposed prey indicate that it 
is less hazardous than indandiones and SGARs, although secondary poisoning is 
possible. In the earliest study, all 5 dogs survived for 8 weeks while consuming 
4–10 mice per day that had ingested either 0.025% or 0.05% warfarin bait for vari-
able durations (Prier and Derse 1962). These investigators concluded that secondary 
poisoning in dogs was “outside the realm of practical possibility”. However, in 
another small trial, dogs consumed nutria (coypu; Myocastor coypus) poisoned with 
0.025% warfarin bait for up to 10 days, one dog succumbed in 8 days and two others 
exhibited coagulopathy and other signs of intoxication (Evans and Ward 1967). 
Mink (Neovison vison) were tested using a similar protocol, and all three subjects 
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exhibited hemorrhage and coagulopathy, succumbing within 16 days (Evans and 
Ward 1967). In a trial in which least weasels (Mustela nivalis) were fed mice 
exposed to either 0.001%, 0.005% or 0.02% warfarin baits for 3 days, intoxication 
in weasels was related to bait potency and residues in prey (0.42, 1.58 and 2.95 μg 
warfarin/g mouse) (Townsend et al. 1984). Weasels that consumed mice on a daily 
basis that had been fed a 0.001% warfarin bait exhibited coagulopathy but survived 
the 90 day exposure period; 1 of 2 weasels ingesting mice fed a 0.005% warfarin 
bait succumbed after 29 days and the survivor exhibited coagulopathy at 90 days; 
both weasels died (days 12 and 57) when given  mice fed a 0.02% warfarin bait. It 
was suggested that such prolonged exposure is unlikely, but nonetheless free- 
ranging weasels “could be at risk” to this AR (Townsend et  al. 1984). Signs of 
hemorrhage, but not mortality, were apparent in mink fed tissues from rabbits that 
had consumed baits mixed with tissues from untreated rabbits to yield diets contain-
ing 2.2–22.5 ppm warfarin (Aulerich et al. 1987). In other studies, European ferrets 
and raccoons fed rodents that had ingested 0.025% and 0.05% warfarin baits for up 
to 15 days survived with no signs of intoxication (Poché and Mach 2001; Mach 
1998 and USEPA 1982 as cited in USEPA 2004).
Secondary exposure studies with other FGARs suggest their risk is generally 
similar to that of warfarin. In a small trial, mongoose (Herpestes auropunctatus) 
were daily fed a single rat that had ingested 0.025% coumafuryl bait for 1, 3, 6 or 7 
days; mongoose consuming rats for 6 or 7 consecutive days succumbed with evi-
dence of prolonged clotting time, while those ingesting rats for 1 or 3 days survived 
without signs of intoxication (Pank and Hirata 1976). In studies with coumatetralyl, 
weasels ingesting mice that had consumed 0.0375% bait ad libitum died between 
days 11 and 68 during the exposure period (anonymous study cited in Joermann 
1998), and a cat consuming Cape sparrows (Passer melanrus) that had ingested 
bread saturated with coumatetralyl (equivalent to 0.053% bait) succumbed, and 
exhibited internal bleeding, after consuming 79 birds over a 14 day period (Heÿl 
1986). On 3 consecutive days, ferrets were offered a dead rat that had been fed 
0.0375% coumatetralyl bait for 3 days, and then returned to a diet of unexposed rats 
for up to 30 days (O’Connor et al. 2003). Of the 10 coumatetralyl-exposed ferrets, 
2 died within 7 days; however those that survived did not exhibit adverse effects that 
could be directly linked to the rodenticide.
Secondary exposure studies with indandione ARs indicate that chlorophacinone, 
diphacinone and pindone may also pose a hazard to mammalian predators and scav-
engers (Evans and Ward 1967; Pank and Hirata 1976; Fisher and Timm 1987 and 
studies derived from unpublished reports summarized by Joermann 1998 and 
USEPA 2004). In nine studies utilizing predators and scavengers that had consumed 
chlorophacinone exposed prey (e.g., baits ranging from 0.005% to 0.1% fed to 
mice, rats, voles, prairie dogs and ground squirrels for varying durations), 32 of 55 
individuals succumbed (7 of 8 mongoose; 3 of 7 coyotes; 1 of 1 red fox Vulpes 
vulpes; 18 of 35 European ferrets; 3 of 4 weasels), and clotting time, when mea-
sured, was often prolonged (USEPA 2004).
While predator or scavenger exposure to chlorophacinone exposed prey was as 
long as 90 days, much of the mortality occurred within days to weeks of exposure. 
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Three reports describe findings of studies in which predatory and scavenging mam-
mals were either fed rodents baited with 0.005% to 0.1% diphacinone, liver from 
diphacinone-poisoned owls or meat containing 0.5 ppm diphacinone, for periods up 
to 18 days (Evans and Ward 1967; Pank and Hirata 1976; Savarie et al. 1979). Of 
the 33 predator or scavenger test subjects, 19 died (3 of 3 mink; 7 of 8 mongoose; 1 
of 2 ermine Mustela ermine; 0 of 5 striped skunks Mephitis mephitis; 3 of 3 dogs; 4 
of 8 rats; 1 of 4 deer mice), and blood clotting time, when measured, was often 
prolonged. In secondary exposure studies in which nutria that had ingested 0.01% 
pindone bait for up to 10 days were fed to dogs and mink, mortality, and signs of 
hemorrhage and coagulopathy, were observed within 6–15 days of exposure (Evans 
and Ward 1967). An interesting conclusion of Evans and Ward (1967) was “the 
demand for nutria as mink and pet food, coupled with the secondary poisoning haz-
ards, rules out the use of these rodenticides for nutria control in coastal areas of the 
United States”. Results of a pindone study in mongoose were more variable. Death 
and prolonged clotting were observed in mongoose following consumption of rats 
baited with 0.025% baits for 1 or 6 days, but surprisingly no mortality or coagulopa-
thy was observed in mongoose following consumption of pindone- exposed rats for 
3 or 10 days (Pank and Hirata 1976).
Second-generation ARs Exposure studies with SGARs generally indicate that 
ingestion of prey containing these compounds poses a high risk to predatory and 
scavenging mammals. Studies have been conducted in which rodents, orally dosed 
with 15 mg brodifacoum/kg body weight or rodents that consumed 0.002% baits, 
were fed to predators or scavengers for 1–52 days (Pank and Hirata 1976; Godfrey 
1985, unpublished reports summarized in Joermann 1998 and USEPA 2004). 
Mortality was observed in 8 of 26 individuals (2 of 5 red fox and gray fox Urocyon 
cinereoargenteus; 1 of 5 mongoose, 4 of 4 weasels; 1 of 6 domestic dogs), with 
signs of intoxication, including coagulopathy, observed in many of the survivors. In 
bromadiolone studies, rodents fed 0.005% to 0.01% baits for varying durations, 
were offered to predatory or scavenging mammalian predators for up to 6 days 
(Pank and Hirata 1976; Lund and Rasmussen 1986; Grolleau et al. 1989, and unpub-
lished reports summarized in Joermann 1998 and USEPA 2004). Of the 26 
bromadiolone- exposed subjects, 6 succumbed (3 of 4 mongoose; 2 of 7 coyotes; 1 
of 11 ermine; 0 of 4 stone marten Martes foina), having been exposed to prey for 3 
or more days. Notably, signs of intoxication including hemorrhage were reported in 
all 10 surviving ermine, modest changes in all 4 stone martens (increased fragility 
of small vessels in musculature on top of skull; Lund and Rasmussen 1986), but no 
observed effects in the 5 surviving coyotes.
During an exposure period ranging up to 10 days, 4 mongoose fed rats that had 
ingested 0.005% difenacoum bait did not succumb, but there was some evidence of 
prolonged coagulation time (Pank and Hirata 1976). In contrast, all 4 weasels con-
suming mice that had ingested 0.005% difenacoum bait died over a 9–33 day expo-
sure period, while another study reported that an exposed weasel survived a 12 day 
exposure period, but exhibited impaired blood clotting (reports summarized in 
Joermann 1998). In a small study in which 2 ferrets consumed mice orally dosed 
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with flocoumafen (10 mg/kg) for 5 days, both survived but exhibited some effects 
on blood coagulation (Bachhuber and Beck 1988 cited in Joermann 1998).
4.2  Secondary Exposure Studies in Birds
First-generation ARs Several feeding studies have been conducted in which 
warfarin- exposed rodents were fed to predatory birds. Formulated diets or 0.005–
0.05% warfarin baits have been fed to tawny owls (Strix aluco), barn owls (Tyto 
alba), black-billed magpies (Pica pica), and an Eurasian buzzard (Buteo buteo) for 
durations ranging from 5 days to as long as 90 days (Townsend et al. 1981, Lee 
1994; Telle 1955 and March 1997 as reviewed in USEPA 2004). Whole body war-
farin residues in mice fed to the tawny owls ranged from 27.4 to 344 μg/mouse, the 
lower concentration corresponding to levels found in mice poisoned with 0.005% 
bait (Townsend et al. 1981, 1984). In this detailed study, warfarin consumption by 
tawny owls was about 0.175  mg/kg body weight per day in a 90  day trial and 
0.78 mg/kg body weight per day in a 28 day trial. While signs of intoxication (e.g., 
internal hemorrhage, prolonged clotting time) were reported in some of these stud-
ies, it is notable that of the 23 warfarin-exposed birds, only two barn owls died (Lee 
1994). In this latter study, rats received a 0.025% warfarin bait formulation, while 
even more potent formulations (up to 0.054%) have been registered in the US 
(USEPA 2011). Based on bait consumption by rats, Lee (1994) estimated the cumu-
lative warfarin dose of the two owls that succumbed to be 86 mg warfarin per kg 
body weight owl (corresponding to about 12 mg warfarin per kg body weight owl 
per day for 5–7 days), with mortality occurring some 2–3 weeks following termina-
tion of warfarin exposure (Lee 1994). However, this estimate is likely a flawed 
 overestimation, as the concentration of the AR in exposed rats was not analytically 
quantified, and warfarin metabolism and excretion by rats, which can be substantial, 
was not considered.
Secondary exposure studies with other FGARs seldom found mortality. Studies 
in which over 50 coumatetralyl-killed Cape sparrows were fed to a spotted eagle 
owl (Bubo africanus) or to a steppe buzzard (Buteo buteo) for 18 days (Hëyl 1986), 
coumatetralyl-poisoned rats were fed to the omnivorous weka (Gallirallus aurtra-
lis) for 3 days (O’Connor et al. 2003), and coumatetralyl-exposed mice were fed to 
buzzards for 2 week (described in Joermann 1998) or to kestrels (Falco tinnunculus) 
for 22 days (Galanos 1991 described in Madden 2002), did not cause mortality of 
these secondary consumers. However, kestrels fed mice that had been poisoned at 
two to four times the label rate did exhibit signs of anticoagulant intoxication at 
necropsy (Galanos 1991 described in Madden 2002). In a small trial, two barn owls 
fed coumafuryl-exposed rats for 10 days survived without apparent intoxication 
(Mendenhall and Pank 1980).
A number of investigations have examined the toxicity of chlorophacinone- and 
diphacinone-exposed rodents (fed 0.005–0.01% bait) offered as food to captive rap-
tors or scavenging birds for durations ranging up to 61 days (e.g., barn owl, great- 
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horned owl Bubo virginianus, saw-whet owl Aegolius acadicus, Mendenhall and 
Pank 1980; American kestrel, Radvanyi et al. 1988; tawny owl, Eurasian buzzard, 
Riedel et al. 1988; great-horned owl, red-tailed hawk Buteo jamaicensis, Askham 
and Poché 1992; American crow Corvus brachyrhynchos, Massey et  al. 1997; 
black-billed magpie, carrion crow Corvus corone and white stork Ciconia ciconia 
as reviewed in USEPA 2004; barn owl, Salim et al. 2014; American kestrel, Rattner 
et  al. 2015). Signs of intoxication (lethargy, behavioral aberrations, wing droop, 
gross and histological evidence of hemorrhage, prolonged clotting time) were 
observed in some of these studies (e.g., Radvanyi et al. 1988; Riedel et al. 1988; 
Massey et  al. 1997; Salim et  al. 2014; Rattner et  al. 2015), but not in others 
(Mendenhall and Pank 1980; Askham and Poché 1992, reviewed in USEPA 2004). 
Rattner et al. (2015) actually derived a dietary-based toxicity reference value (TRV; 
~40 μg chlorophacinone/kg kestrel per day) for which 50% of the exposed non- 
target raptors would exhibit coagulopathy. It is remarkable that of these eight reports 
describing indandione secondary exposure trials utilizing nearly 100 predatory or 
scavenging birds, mortality was limited to two great-horned owls and a saw-whet 
owl that consumed diphacinone-poisoned mice for 5 days, and these three owls did 
not exhibit overt signs of intoxication (Mendenhall and Pank 1980).
In an often cited study by Savarie and coworkers (1979), golden eagles (Aquila 
chrysaetos) were fed muscle from diphacinone-treated sheep (Ovis aries) (2.7 mg 
diphacinone/kg muscle) for 5–10 days. While these diphacinone concentrations in 
sheep muscle are quite unlikely for livestock and wild game ingesting bait in a field 
setting (e.g., see data for wild pigs in Eisemann and Swift 2006), adverse effects 
(e.g., extreme weakness, ataxia, hemorrhage, prolonged prothrombin time, reduced 
hematocrit, but not mortality) were observed in golden eagles that received an esti-
mated cumulative dose of 1.08 mg/kg body weight. Likewise, dietary exposure of 
eastern screech-owls (Megascops asio) to graded concentrations of diphacinone 
mixed into bird of prey diet for 7 days evoked similar effects at a cumulative dose 
of 1.68 mg/kg body weight (Rattner et al. 2012a). From these diphacinone data sets, 
the lowest-observed-adverse-effect level (LOAEL) for prolonged clotting time was 
estimated to be 110 μg/kg body weight per day in golden eagles and 160 μg/kg body 
weight per day in screech-owls, and these values have been used in some predatory 
bird risk assessments (Eisemann and Swift 2006, Rattner et al. 2012a, b). Using a 
statistically more robust approach than the LOAEL, Rattner and coworkers (2012b) 
derived a dietary-based TRV of 170 μg diphacinone/kg owl per day for a week at 
which 10% of the non-target raptors would exhibit reduced hematocrit (i.e., classi-
fied as anemic) associated with coagulopathy (Rattner et al. 2012b). Notably, using 
data for diphacinone-poisoned rats from Hawaii (extreme value of 12  μg 
diphacinone/g liver, E.B. Spurr, USGS as cited in Rattner et al. 2012a), and assum-
ing that owls fed exclusively on these rats, the dietary dose would be ~145 μg 
diphacinone/kg owl per day, which approaches this TRV (i.e., 170 μg diphacinone/
kg owl per day for a week) for AR-induced anemia.
Second-generation ARs The most detailed avian studies have been conducted with 
brodifacoum, which is the most potent of the group (Joermann 1998; US EPA 
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2004). These trials generally found high levels of mortality with secondary expo-
sure. Several studies have been conducted in which barn owls were fed rodents 
(Rattus sp., Mus sp.) that had been exposed to environmentally realistic concentra-
tions of brodifacoum baits (baits containing 0.002–0.005% active ingredient) 
(Mendenhall and Pank 1980; Newton et al. 1990; Gray et al. 1994; Lee 1994; Wyllie 
1995). Many of the owls fed rodents for as long as 15 days exhibited signs of intoxi-
cation (coagulopathy, hemorrhage, pale viscera) and a substantial number of birds 
died during these trials (5 of 6 owls succumbed – Mendenhall and Pank 1980; 4 of 
6 died – Newton et al. 1990, 3 of 4 died – Lee 1994, and 1 of 4 died – Gray et al. 
1994, 4 of 10 died – Wyllie 1995). Some of these studies attempted to describe the 
cumulative concentration of brodifacoum in consumed rodents that would result in 
barn owl mortality; estimates are quite variable ranging from 0.15 to 0.18 mg/kg 
owl (Newton et al. 1990) to 5.4 mg/kg owl (Gray et al. 1994). Lee (1994) estimated 
a high cumulative concentration of 9.68  mg brodifacoum/kg owl, but since this 
value assumed no rodenticide metabolism or elimination by the rats, it should be 
discounted. Furthermore, even those estimates that quantified brodifacoum in 
rodents that were ingested (~15.36 μg/mouse) are compromised by the regurgitation 
of pellets by owls that contain rodenticide (perhaps as much as 27% of the exposure 
dose; Newton et al. 1990, 1994). American kestrels fed tissue from brodifacoum- 
exposed voles containing varying concentrations of this AR for 4 days exhibited 
mortality principally at the greatest dose (6.0 μg brodifacoum/kg vole) (LaVoie 
1990). It was estimated that kestrels that succumbed could have consumed up to 
7.3  mg brodifacoum/kg body weight (LaVoie 1990). Godfrey (1985) fed 
brodifacoum- dosed rabbits to harrier hawks (Cirus approximans) and suggested 
that the dose evoking mortality in hawks was about 6.5 mg/kg, but in contrast to the 
aforementioned reports, downplayed its risk. There are several other unpublished 
studies documenting mortality and overt signs of intoxication in red-tailed hawks, 
red-shouldered hawks (Buteo lineatus), American kestrels, Eurasian buzzard and 
laughing gulls (Larus atricilla) (Howard and Marsh 1978, Savarie and LaVoie 1979, 
Lutz 1987, ICI Americas, Inc. 1979 all of which are summarized in Joermann 1998 
and USEPA 2004).
Secondary exposure studies with raptors indicate that bromadiolone may be 
slightly less toxic than brodifacoum. For barn owls fed bromadiolone-exposed 
rodents (baits containing 0.005% active ingredient) for as long as 10 days 
(Mendenhall and Pank 1980; Lee 1994; Wyllie 1995), some birds exhibited signs of 
intoxication and hemorrhage, but when compared to the aforementioned brodifa-
coum trials, mortality was more limited (1 of 6 owls succumbed – Mendenhall and 
Pank 1980; 3 of 4 owls died – Lee 1994, 0 of 18 owls died – Wyllie 1995). An esti-
mate of the cumulative bromadiolone dose based on concentration in ingested prey 
that would result in death of captive barn owls is not available. These types of stud-
ies with other raptors (e.g., red-tailed hawk and great horned owl, Bubo virginianus, 
Poché 1988; buzzard, Grolleau et al. 1986 and Lutz 1986 described in Joermann 
1998 and USEPA 2004) yielded similar findings, namely that rodents that have 
ingested commonly used bromadiolone baits (0.0025–0.01% active ingredient) for 
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several days evoked less pronounced signs of toxicity in captive raptors than 
observed in raptors consuming brodifacoum-exposed rodents.
Ingestion of rodents exposed to difenacoum baits (0.005% active ingredient) 
by barn owls for durations ranging from 1 to 15 days resulted in limited mortality 
(all 6 survived – Mendenhall and Pank 1980, all 6 survived – Newton et al. 1990, 
1 of 4 died, Gray et al. 1994). The single owl that succumbed was estimated to 
have consumed 3.7 mg difenacoum/kg over a 13 day period. There was evidence 
of impaired blood clotting and hemorrhage in many of the owls receiving treated 
rodents for 3 or more days. In contrast to findings in barn owls, ingestion of dife-
nacoum-exposed mice by tawny owls (Strix aluco) for an extended period resulted 
in mortality of all 6 owls between days 8 and 41 of exposure (anonymous 1981 
cited in Joermann 1998).
Limited data are available for controlled secondary exposure studies with dife-
thialone. Barn owls were fed bandicoot rats (Bandicota bengalensis; orally dosed 
with the median lethal dose of difethialone) for 1 day, followed by a 20 day recovery 
period, then offered exposed rats for 3 consecutive days, followed by another recov-
ery period, and then offered difethialone-dosed rats a third time (Saravanan and 
Kanakasabai 2004). In the third exposure phase of this study, during which the owls 
were to be offered difethialone-dosed rats for 6 consecutive days, all owls suc-
cumbed before the target exposure duration and exhibited either overt or internal 
hemorrhage.
In secondary exposure studies with flocoumafen, barn owls fed exposed rodents 
(baits containing 0.005% active ingredient) for up to 15 days exhibited varying 
mortality among studies (1 of 4 died – Gray et al. 1994, 3 of 4 died – Lee 1994, 1 of 
5 died – Newton et al. 1994). Many of the owls exhibited overt signs of intoxication. 
Notably, molting in one owl during the course of its exposure may have exacerbated 
hemorrhage and contributed to mortality (Newton et  al. 1994). Estimates of the 
cumulative dose of flocoumafen associated with mortality ranged from 0.93 to 
2.2 mg/kg owl (Gray et al. 1994; Newton et al. 1994). Limited work in other species 
includes mortality of 2 of 5 buzzards (Buteo buteo) fed flocoumafen baited mice for 
5 days (Ueckermann and Lutz 1986 cited in Joermann 1998).
4.3  Some Conclusions from Secondary Exposure Studies
While acute toxicity data are available for a dozen ARs (Table 3.1), only 10 com-
pounds have been examined in secondary exposure studies with birds and mam-
mals. To the best of our knowledge, only one secondary exposure study has been 
conducted in reptiles (5 rattlesnakes, Crotalus viridis, exposed to bromadiolone- 
baited mice survived without signs of intoxication; Poché 1988). Because there are 
no formally harmonized protocols or test species for secondary exposure studies, 
comparisons among ARs and species remain challenging. Most of the studies are 
fixed-dose, with a variable exposure period, and use death as the principal endpoint, 
but note signs of intoxication (e.g., bruising, hematomas, hemorrhage and 
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prolonged clotting time). The percent active ingredient of the bait or food used to 
expose prey varies considerably. The duration of prey exposure to bait formulation 
is usually in the order of days, while exposure of the secondary consumer is far 
more variable, ranging up to 3 months. Such data sets are not particularly amenable 
for examining dose-response relationships, and estimating effect thresholds and 
dietary- or tissue-based toxicity reference values.
Despite fewer and smaller secondary exposure studies being conducted with 
mammalian predators and scavengers compared to raptorial and scavenging birds, 
nearly all ARs caused some mortality (exceptions coumafuryl, flocoumafen). To the 
best of our knowledge, no difethialone secondary exposure studies have been con-
ducted in mammals. Nonetheless, in the comparative risk analysis of the USEPA 
(2004, 2011), the “opportunity for secondary exposure to exceed the median lethal 
dose was estimated to be greater for brodifacoum and difethialone” (USEPA 2011). 
In contrast to birds, substantial secondary mortality was even noted in mammalian 
studies with the FGARs chlorophacinone and diphacinone.
In studies comparing mortality rate in predators fed prey that had consumed 
either realistic bait formulations or AR-containing tissue diets thought to mimic 
realistic exposures, brodifacoum appears to pose the greatest risk among ARs to 
predatory and scavenging birds (Joermann 1998; USEPA 2004, 2011). The data 
from the described exposure scenarios suggest that bromadiolone, difenacoum, flo-
coumafen and difethialone are slightly less hazardous than brodifacoum, but pose 
greater risk to predatory and scavenging birds than the FGARs warfarin, coumate-
tralyl, coumafuryl, chlorophacinone and diphacinone. Some, but not all, of these 
ARs have been examined in comparative risk models that incorporate pharmacoki-
netic accumulation and elimination data. These studies have also found that SGARs 
pose the greatest risk, with brodifacoum (Fisher et al. 2004; USEPA 2004, 2011) 
and difethialone (USEPA 2004, 2011) identified as posing the greatest risk to preda-
tory and scavenging birds (USEPA 2004, 2011).
5  Chronic Toxicity Studies
Traditionally, chronic studies entail > 90-day oral, dermal or inhalation exposures 
in rodent and occasionally other test species (e.g., OECD 1998, 2009). It has been 
suggested that such testing with ARs is inherently difficult to conduct, necessitat-
ing some dose levels below the analytical limit of detection for some compounds 
(IPCS 1995, ECHA 2003). Based upon the nature of AR use (i.e., non-food appli-
cation), no chronic ecotoxicity studies are required for registration, and thus only 
limited data are available (e.g., USEPA 1998; European Union 2010). For example, 
a 90-day dietary exposure to warfarin in laboratory rats yielded an LD50 (based on 
measured food consumption) of 0.077 mg/kg/day (about 1/20th of the 1-day acute 
oral LD50: 1.6  mg/kg), with a “safe” concentration (no mortality to 300 days) 
estimated to be 0.02 mg/kg-day (Hayes 1967). As previously described (Sect. 3 
Subacute Dietary Toxicity Studies), broiler chicks fed vitamin K deficient diets 
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containing warfarin (25–100 ppm) for up to 20 weeks exhibited dose-dependent 
increases in mortality, prolonged prothrombin time, hemorrhage and impaired 
growth compared to controls, although no attempt was made to estimate a safe 
level of exposure (Veltmann et al. 1981). However, the objectives and design of the 
rat study (Hayes 1967 focusing on generating a median lethal dose) and chicken 
study (Veltmann et al. 1981, focusing on warfarin-induced endocardial lesions as 
affected by a vitamin K deficient diet) were quite different and do not permit a 
direct comparison of warfarin toxicity between these species. Chronic oral toxicity 
studies with chlorophacinone in rats revealed mortality at doses > 0.020 mg/kg 
body weight/day, with evidence of hemorrhage and prolonged clotting time at > 
0.010  mg/kg body weight/day (ECHA 2014a). In a 90-day feeding trial with 
diphacinone, 2 of 72 rats succumbed (dietary doses of 0.065 and 0.25 mg/kg diet), 
with signs of subdural hemorrhage; remarkably none of the survivors had pro-
longed prothrombin time, but 10 treated rats did exhibit a pinkish eye discharge 
that was not dose-related (Elias and Johns 1981). In a chronic study in which dogs 
were orally dosed with bromadiolone, mortality and signs of intoxication (hemor-
rhage, prolonged clotting time) were apparent at doses > 20 mg/kg/day, while no 
effects were apparent at 8 mg/kg/day (ECHA 2014b). In contrast, evidence of hem-
orrhage and prolonged clotting time were apparent in a chronic oral toxicity study 
with New Zealand white rabbits receiving > 0.001  mg/kg/day (ECHA 2014b). 
Several repeated dose studies have been conducted with difenacoum, with dietary 
concentration > 0.1  mg/kg body weight/day causing mortality in rats (ECHA 
2014c). While it is certainly possible, and even probable, that non-target wildlife 
might encounter chronic low-level AR exposure (continuous or sporadic), the tox-
icity associated with long-term AR exposure in non-target wildlife has not been 
examined in a controlled exposure setting.
6  Sublethal Effects
As described in the Introduction and illustrated in Figs. 3.2, 3.3 and 3.4, the princi-
pal mechanism of action of ARs entails inhibition of the vitamin K cycle resulting 
in under-carboxylation of the clotting factors II, VII, IX and X yielding dysfunc-
tional clotting and prolonged clotting time or failure of blood to clot altogether. 
Based upon decades of warfarin (Coumadin) use in humans, and extensive studies 
in other mammals, the dose-response relationship for warfarin (and related com-
pounds) is known to be very steep. There are established procedures and nomo-
grams for determining the appropriate Coumadin maintenance dose for patients of 
varying genotypes, and these are largely dependent on measurement of prothrombin 
time to titrate the desired “therapeutic effects” (e.g., Anderson et al. 2007). Prolonged 
clotting time, bruising, frank bleeding, microscopic evidence of bleeding, blood in 
droppings and urine, anemia and pallor are frequently noted “toxicological effects” 
in AR exposure studies in wildlife. These sublethal responses are part of the sequelae 
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of AR intoxication in higher vertebrates that are linked to physiological condition 
and mortality (see Fig. 3.3, Rattner et al. 2014a).
6.1  Prolonged Clotting Time
Due to greater societal concerns for humans, domesticated and companion animals, 
the effects of ARs on hemostasis in mammals are far better characterized than in 
birds and lower vertebrates. In addition, there are some notable inter-specific differ-
ences in clotting mechanisms between mammals and birds (e.g., less functional 
intrinsic clotting pathway in birds, Belleville et al. 1982, James et al. 1998, Thomson 
et al. 2002, Ponczek et al. 2008, Harr 2012; mammals have platelets while birds 
have thrombocytes that spread less efficiently and do not aggregate as readily, 
Schmaier et al. 2011), and some suggestion that avian whole blood clotting time is 
slower than that of mammals (Belleville et al. 1982; Scanes 2015). A variety of clot-
ting assays have been used to document coagulopathy following AR exposure in 
captive wild birds and mammals. Clotting tests range from timed visual observa-
tions of whole blood (e.g., fibrin formation in sample detected in  a sequentially 
broken capillary tube or with a hooked needle, Evans and Ward 1967, Mendenhall 
and Pank 1980; cessation of movement of a metal rod in a rocked capillary tube 
blood sample, Newton et  al. 1990; time for clot formation in a serum collection 
tube, James et al. 1998; activated clotting time by assessing microclot formation of 
a sample drawn into a tube containing diatomaceous earth, Webster et al. 2015) to 
fibrometer-based assays of citrated plasma using purified reagents to measure pro-
thrombin time and Russell’s viper venom time (e.g., Savarie et al. 1979; Littin et al. 
2002, Bailey et al. 2005; Rattner et al. 2010; Webster et al. 2015). More detailed 
information on blood sample collection requirements, and the selection and conduct 
of assays to assess AR effects, is outside the scope of this chapter (see Triplett and 
Harms 1981; Brooks and De Laforcade 2012). However, it is worth noting that gen-
eration and standardization of clotting time data for birds has been hampered 
because commercially available mammalian clotting assay kits do not perform very 
well in tests of citrated bird plasma (e.g., Guddorf et al. 2014). Furthermore, there 
are currently no commercial sources of avian thromboplastin, which necessitates 
preparation and characterization of crude avian thromboplastin extracts to conduct 
prothrombin time assays (e.g., Rattner et al. 2010; Webster et al. 2015). As clotting 
time in birds exposed to ARs may be many times longer than basal values in healthy 
unexposed individuals, even crude clotting tests may be helpful in diagnosing AR 
exposure (James et al. 1998).
In studies with captive wildlife, clotting time has been used to detect coagulopa-
thy (adverse effect) as a toxicological endpoint associated with exposure to a par-
ticular AR (concentration known or estimated) for varying durations (see Sect. 4. 
Toxicity Studies Involving Secondary Exposure). In some studies involving severe 
AR exposure, a simple descriptive statement is made implying that blood did not 
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clot (e.g., 30+ min, Pank and Hirata 1976; 27 min to clot, James et al. 1998), while 
other studies utilizing sublethal exposures report clotting time values and make sta-
tistical comparisons to unexposed animals or baseline values generated prior to AR 
exposure (Savarie et  al. 1979) to estimate a LOAEL (Eiseman and Swift 2006). 
Some toxicokinetic studies have demonstrated the well-known lag time between AR 
exposure and the onset of prolonged clotting time associated with clearance of 
active carboxylated clotting factors during the onset of VKOR inhibition (e.g., Littin 
et al. 2002; Rattner et al. 2011, 2014b). The time course to restore clotting time to 
baseline following termination of AR exposure has also been monitored in a few 
studies (Savarie et  al. 1979; Rattner et  al. 2014b). It has been suggested that an 
increased prothrombin time by more than 25% is suggestive of AR exposure 
(Shlosberg and Booth 2006). Rattner and coworkers (2012a, 2014b, 2015) have 
defined the threshold for AR-induced coagulopathy as values exceeding control or 
baseline clotting time by more than two standard deviations; the number of affected 
individuals at a given dietary dose or tissue residue level was used  to generate 
dietary-based and tissue residue-based toxicity reference values for coagulopathy. It 
is surprising that only a few studies have attempted to relate changes in clotting time 
to AR tissue residues (e.g., Rattner et al. 2014b, 2015). The authors are not aware of 
reports that describe a level of AR-induced coagulopathy that results in death. 
However, AR-exposed animals with coagulopathy are clearly compromised, and the 
proximate cause of death may be a physical injury exacerbated by coagulopathy, 
which may be considered the ultimate cause of death.
6.2  Decreased Hematocrit and Anemia
While it is well-known that companion animals and non-target wildlife suffering 
from AR toxicosis commonly exhibit decreased hematocrit (packed cell volume) 
due to blood loss and may be clinically classified as anemic (e.g., Mount et al. 1986; 
Murray 2011), it is surprising that few AR exposure studies with wildlife monitor 
and report hematocrit in test subjects. In various trials involving golden eagles 
(Savarie et al. 1979), eastern screech-owls (Rattner et al. 2012a, 2014b), American 
kestrels (Rattner et al. 2015) and Japanese quail (Webster et al. 2015) exposed to 
environmentally realistic concentrations of ARs, some individuals had hematocrit 
values of <30 and could be classified as anemic (i.e., >25% decrease in hematocrit 
compared to controls; e.g., Goodwin et al. 1992). In studies with diphacinone, the 
LOAEL for anemia in owls was 0.36 mg diphacinone consumed/kg body weight- 
day for a week and toxicity reference value estimates for which 10% of exposed 
owls would exhibit anemia was 0.17 mg diphacinone consumed/kg body weight- 
day for a week (Rattner et al. 2012b). Although many disease states and other toxi-
cants (most notably lead) may cause anemia, measurement of hematocrit should be 
more frequently incorporated into AR exposure studies in non-target wildlife.
B.A. Rattner and F.N. Mastrota
71
6.3  Gross and Microscopic Evidence of Hemorrhage
Many of the aforementioned AR exposure studies with captive wildlife (see Sect. 4. 
Toxicity Studies Involving Secondary Exposure) describe bruising, frank bleeding 
from the oral cavity, nares, rectum, cloaca, and talons, and blood in droppings, scat 
and urine. Evidence of pallor of mucous membranes may be apparent. Even with 
sublethal AR exposure, euthanized animals may exhibit hemorrhage (e.g., skin, ali-
mentary tract, peritoneal cavity, kidney, liver) and excessive bleeding during nec-
ropsy. The severity of these overt signs is generally dose-dependent, although their 
appearance may be delayed for days to even weeks following the onset of AR expo-
sure (USEPA 2004). There is some concern that hemorrhage and excessive bleeding 
can be initiated by self-trauma (cage sustained injuries), and even capture and han-
dling in more active captive species.
Surprisingly few controlled exposure studies in wildlife have undertaken histo-
pathological evaluations to identify cellular lesions and hemorrhage associated with 
AR exposure. While microscopic evidence of hemorrhage in heart, lung, kidney, 
liver and skeletal muscle, and tissue necrosis have been reported, their prevalence in 
these tissues is not always dose-related (perhaps a function of examining too few 
sections per tissue and even artifacts related to tissue trimming and processing) 
(e.g., Rattner et al. 2011, 2012a, 2015). Histological observations alone are not con-
sidered diagnostic of AR intoxication (DuVall et al. 1989).
6.4  Other Sublethal Responses
Aside from signs of intoxication related to coagulopathy, there are limited data on 
other sublethal effects associated with AR exposure. Other effects noted in AR acute 
oral LD50 studies include lethargy, piloerection, diarrhea, and anorexia (USEPA 
2011). Behavioral responses of AR-exposed target species have been described in 
both laboratory studies and field trials (e.g., ranging from no apparent response to 
lethargy, reduced grooming, escape response and thigmotactic behavior, and unco-
ordinated and staggering gate; Cox and Smith 1992, Hooker and Innes 1995, Littin 
et al. 2002, Brakes and Smith 2005). However, behavioral changes in AR-exposed 
captive wildlife are principally descriptive in nature (e.g., anorexia, lethargy, 
reduced agility, wing droop) and are commonly apparent with many other types of 
contaminant intoxication (i.e., not AR-specific). Studies have yet to examine 
changes in complex behavioral processes (e.g., prey capture efficiency) that could 
affect survival of free-ranging wildlife.
Laboratory studies provide little information on how sublethal effects of ARs 
might alter fitness of free-ranging wildlife. There is some evidence of impaired 
growth in layer and broiler chickens chronically ingesting feed containing warfarin 
at concentrations at and below those found in some rodent bait products (Veltmann 
et al. 1981). Indices of body condition have been reported to be negatively related to 
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AR residues in free-ranging stoats (Elmeros et al. 2011), although no such relation 
has been reported in AR exposure studies with captive wildlife. Nonetheless, in a 
study of captive red-tailed hawks fed chlorophacinone-poisoned prairie dogs during 
winter, ptiloerection (fluffing of feathers) was observed in several hawks upon 
release (notably birds with prolonged clotting  time), suggestive of compromised 
physiological condition (Vyas et al. 2014).
7  Differences in AR Sensitivity Among Taxa
Based upon the toxicity data generated from controlled exposure studies in birds 
and mammals, it is not possible to make a general statement of the relative sensitiv-
ity of these two vertebrate classes to ARs. Using mortality as an endpoint, examina-
tion of acute, subacute dietary and secondary exposure data from the present 
summary and others (Joermann 1998; USEPA 2004, 2011) suggests that mammals 
are more sensitive to ARs than birds, particularly for first-generation hydroxycou-
marins and intermediate-generation indandiones. Notably, Watanabe and coworkers 
(2010) demonstrated that while hepatic VKOR activity of laboratory rats is about 
seven times greater than chickens (i.e., Vmax of 514.5 pmol/min/mg protein for rat 
vs. 71.7 pmol/min/mg protein for chicken), the inhibitory constant for rats is 40 
times lower than for chickens (i.e., Ki of 0.28 μM for rats vs. 11.3 μM for chickens), 
and the ability to hydroxylate warfarin is about eight times lower in rats than in 
chickens (i.e., 196 pmol/min/nmol P450 for rat vs. 1660 pmol/min/nmol P450 for 
chicken). In a recent pharmacokinetic analysis, Watanabe et al. (2015) suggested 
that while warfarin is more readily metabolized by chickens than rats, its half-life in 
chickens is relatively long compared to mammals, and thus factors other than 
metabolism may be critical determinants of differences in sensitivity among verte-
brate classes. It was postulated that blood albumin in chickens may have greater 
warfarin binding capacity (i.e., limiting opportunity for free warfarin to interact and 
bind to VKOR), resulting in longer half-life and less toxicity (Watanabe et al. 2015). 
There is also the possibility that differences in FGAR sensitivity between vertebrate 
classes could be due to differences in blood clotting mechanism (see Sect. 6). The 
limited data for reptiles (Brooks et al. 1998; Weir et al. 2015, 2016) does not permit 
a generalized sensitivity comparison to higher vertebrates.
As noted by others (e.g., Joermann 1998), the potential hazard of individual sub-
stances seems to differ markedly among avian species, but less so for mammals. 
Remarkable differences in AR sensitivity have been reported among some omnivo-
rous and predatory birds compared to commonly tested avian granivores (e.g., LD50 
for diphacinone in American kestrels is 20–30 times less than for granivores; see 
Eason et al. 2002; Rattner et al. 2011, 2012a, b). Studies with warfarin in chicken, 
ostrich (Stuthio camelus), mallard, crow (Corvus macrorhynchos) and snowy owl 
(Bubo scandiacus) describe inter-specific differences in warfarin metabolism that 
could account for inter-specific differences in sensitivity (Watanabe et  al. 2010, 
2015). As previously suggested (Rattner et al. 2014a), it might be possible that AR 
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tolerance in some non-target species may be related to differences in the primary 
structure of VKOR that has been reported in genetically resistant rodents (Pelz et al. 
2005). Preliminary investigation of the primary structure of VKORC1L1 in 14 spe-
cies of birds using GenBank suggests that the primary structure of VKORC1L1 is 
highly conserved in the region of the active site (N.  Karouna-Renier, personal 
communication).
While the data presented in this chapter describes the toxicity of ARs in con-
trolled exposure trials, it does not address exposure pathways and risk to non-target 
birds and mammals. The USEPA has devoted considerable effort assessing the risk 
associated with direct bait ingestion (primary exposure) and consumption of prey 
containing residues (secondary exposure) of current use rodenticide formulations in 
the United States (USEPA 2011). Based on toxicity, toxicokinetics and exposure 
modelling, under some scenarios warfarin, chlorophacinone, brodifacoum and dife-
thialone exceeded levels of concern for non-target birds and mammals. Consumption 
of SGAR-exposed prey, and to lesser degree FGAR-exposed prey, also exceeded 
levels of concern for predatory birds and mammals. These and other findings have 
resulted in a range of risk mitigation measures (e.g., changes in product labeling, 
permitted uses and points of sale; required use of bait stations to minimize non- 
target exposure) in the United States, with some harmonization in Canada (Health 
Canada 2012). The European Community Biocidal Products Directive (98/8/EC) 
also highlights significant or unacceptable risk of some SGARs to non-target wild-
life, with SGAR use and mitigation measures at the discretion of EU member states 
to be re-evaluated by the end of 2017 (European Union 2012).
8  Critical Information Gaps and Research Needs
Although there are extensive AR toxicity data on acute, subacute and secondary 
AR exposure scenarios in non-target wildlife, there are some critical information 
needs that might ideally be derived under controlled exposure conditions in non-
target wildlife that would ultimately enhance ecological risk assessments. These 
include (i) comparative toxicity data, particularly for understudied taxa, (ii) sub-
lethal effects seemingly unrelated to coagulopathy, (iii) response to AR mixtures 
and sequential exposure, and (iv) vitamin K status and provitamin diet supplemen-
tation in toxicity studies.
8.1  Comparative Toxicity and Understudied Taxa
From a phylogenetic perspective, our knowledge of lethality (LD50, LC50) for a 
dozen ARs is relatively complete for commonly used test species. However, inter- 
specific differences within the vertebrate class Aves (and perhaps Mammalia) may be 
substantial, and deserve further attention so that species sensitivity distributions 
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might be constructed and used in risk assessments. Perhaps the most critical question 
is the relatively sensitivity of predatory and scavenging birds compared to commonly 
tested mallard and bobwhite, as limited comparative data indicates that the former 
may be significantly more sensitive than the latter (Eason et al. 2002; Rattner et al. 
2011; 2012a, b). Clearly, further genetic, metabolic and pharmacokinetic studies in 
non-target wildlife might reveal the causes of inter-specific differences in sensitivity. 
The paucity of toxicity data for reptiles, and its absence altogether for amphibians, 
warrant generation of such data for these vertebrate classes, particularly in view of 
potential AR hazards associated with eradication of rodents on remote islands in 
temperate zones. Such data for reptiles and amphibians should employ contemporary 
oral toxicity testing schemes (and possibly dermal toxicity for amphibians) that min-
imize numbers of test subjects (e.g., OECD 2008), and for FGARs, a multi-day 
rather than single day acute oral dosing scheme (see Sect. 2. Single-day versus multi-
day exposures on AR toxicity). It is noteworthy that there is considerable interest in 
potential exposure and toxicity to fish and other aquatic species at sites of AR use 
(e.g., Primus et al. 2005; Pitt et al. 2015; Riegerix and Tillitt 2015) and also their use 
in AR mechanistic studies (Weigt et al. 2012). While substantial data are available on 
some aquatic species (e.g., IPCS 1995; USEPA 2015), their review and discussion 
are outside of the scope (i.e., “wildlife”) of this chapter.
8.2  Sublethal Effects of ARs Unrelated to Coagulopathy
With the exception of coagulopathy, limited data are available on other responses 
that could be associated with AR exposure in non-target wildlife. Vitamin K and its 
antagonists (including ARs) are now known to affect many biochemical and cellular 
processes beyond coagulation (Benzakour 2008). Vitamin K hydroxyquinone serves 
as a cofactor for γ-glutamyl carboxylation of specific glutamic acid residues 
(Fig. 3.3) of certain proteins (Gla-proteins), and this along with other non-cofactor 
functions appear to affect cellular metabolism and signaling, inflammation, oxida-
tive damage and sphingolipid synthesis (van den Berg and Nauta 1975; Kater et al. 
2002; Shearer and Newman 2008).
In women, the hazards of oral AR use during pregnancy to the developing 
fetus are well-documented (e.g., impaired fetal development, mental retardation, 
life- threatening hemorrhage, fetal warfarin syndrome; Hall et al. 1980; Stevenson 
et al. 1980), and teratogenic responses have been studied using rodent and zebra 
fish (Danio rerio) as animal models (Howe and Webster 1992; Weigt et al. 2012). 
Somewhat related are findings in barn owls that suggest potential adverse effects 
on egg hatching and fledging rates (Naim et al. 2011; Salim et al. 2013), although 
the toxicity pathway is not clear (i.e., coagulopathy or other effects of vitamin K 
antagonism), and it is certainly possible that these responses could be indirect 
nutritional effects. Clinical observations in children receiving long-term warfarin 
therapy have documented reduced bone density related to vitamin K-antagonism 
(Barnes et  al. 2005), although changes in bone density and breaking strength 
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were not apparent in a study of raptors from the United Kingdom (Knopper et al. 
2007) and have yet to be investigated in studies with captive wildlife. An associa-
tion between notoedric mange and AR exposure has been described in bobcats 
(Lynx rufus) residing in urban areas in southern California (Riley et al. 2007). 
While this relationship may be correlative rather than causal, incidence of mange 
could be related to impaired immune function, potentially caused by AR exposure 
(Eichbaum et al. 1979; Kater et al. 2002; Popov et al. 2011). These findings suggest 
that chronic AR exposure might evoke some sublethal effects in non-target birds 
and mammals (e.g., impaired reproduction, teratogenesis including skeletal 
defects, altered immune function) which would be of concern to risk assessors 
and natural resource managers. These hypotheses have yet to be tested, and 
might be best resolved by studies with captive wildlife. Considering the preva-
lence of accumulated AR residues in a large proportion of many populations of 
predatory and scavenging wildlife, the significance of sublethal exposure and its 
long-term consequences at the level of the individual or population remain an 
important unanswered question.
8.3  Responses to AR Mixtures and Sequential Exposures
Studies documenting exposure in free-ranging wildlife frequently report the pres-
ence of multiple SGARs, and occasionally a combination of FGARs and SGARs in 
a single individual (reviewed in Rattner et al. 2014a). Given the similar mode of 
action of all FGARs and SGARs, the toxicity of multiple ARs are expected to be 
more or less additive. In one highly cited report (Thomas et al. 2011), the summed 
hepatic concentrations of various SGARs and incidence of signs of intoxication 
were examined using logistic regression to predict the likelihood of death of a bird 
of prey with a given residue of SGARs. However, the relative potency of various 
ARs for inhibiting VKOR is highly variable, and the validity of their use in additive 
toxicity models (e.g., toxic units or equivalents) most certainly deserves further 
examination, potentially by in vivo or in vitro testing.
One of the key challenges in AR toxicity data in risk assessments is that test 
protocols routinely utilize no-choice continuous exposure conditions. While these 
test conditions may be somewhat more realistic for non-target wildlife during 
remote island eradication projects that yield an abundance of AR-exposed rodent 
prey, they are likely unrealistic of exposure patterns routinely encountered in rural, 
suburban and urban settings. Notably, combined SGAR-FGAR exposures and their 
timing have marked effects on AR toxicity in laboratory rats (e.g., Mosterd and 
Thijssen 1991), and effects of sequential AR exposure are currently being investi-
gated in American kestrels (Rattner, unpublished data). Testing or modelling effects 
of various combinations of ARs, and intermittent and sequential AR exposure seems 
warranted.
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The combined effect of simultaneous exposure in wildlife to ARs and other com-
mon bioaccumulating environmental contaminants, such as lead, deserves further 
investigation. For non-target scavenging birds, ingestion of spent lead ammunition 
is a well-known hazard in the United States and elsewhere (Golden et al. 2016). 
While the mechanisms of toxicity of ARs and lead differ vastly, both of these toxi-
cants can cause anemia. It is certainly possible that sequential exposure (AR-lead, 
lead- AR) could occur and exacerbate overall toxicity.
8.4  Vitamin K Status and Provitamin Diet Supplementation
Research is needed to better understand the interaction of dietary vitamin K intake 
in wildlife and AR toxicity. Impaired blood coagulation was in fact the basis of the 
discovery of vitamin K. A hemorrhagic syndrome in chickens dating back to the 
1930’s led to the discovery of an antihemorrhagic lipid soluble component found in 
vegetable and animal sources (Vitamin K, Dam 1935). Subsequently, it was demon-
strated that prothrombin activity (Factor II) decreased in vitamin K deficient chicks 
(Dam et al. 1936), and by the 1950’s it was recognized that the synthesis of other 
clotting factors (VII, IX, X) were also depressed by diets deficient in vitamin K 
(reviewed in McDowell 2000). In mammals, it is known that a combination of 
sources, namely diet [vitamin K1 (phylloquinone) and perhaps other forms of vita-
min K] and gut flora [vitamin K2 (various menaquinones)], are needed to meet the 
vitamin K requirement to prevent deficiency (reviewed in McDowell 2000; Shearer 
and Newman 2008). Despite intestinal gut flora sources of vitamin K, animals may 
become deficient if placed on a vitamin K-free diet (McDowell 2000). In domestic 
poultry, and presumably companion and wild birds, digestive tract synthesis of vita-
min K is less than half of that found in domestic mammals and man (McDowell 
2000). Because of the relatively shorter digestive tract of bird, synthesis of vitamin 
K occurs near the distal end of the tract which limits absorption, and transit time of 
food passage is rapid (McDowell 2000). Thus, poultry (and presumably other avian 
species) are seemingly more dependent on dietary sources of vitamin K than mam-
mals. Furthermore, hepatic VKOR activity in 4–5 week old poultry chicks is about 
10% of that found in laboratory rats, which minimizes recycling of vitamin K and 
likely accounts for their greater dietary requirement than rats and other mammals 
(Will et al. 1992; McDowell 2000).
Vitamin K dietary requirements have been established for man, and domestic and 
companion animals (e.g., McDowell 2000). However, vitamin K status in man is not 
assessed by simple plasma measurements of phylloquinone alone, but rather as a 
combination of measures of clotting time, proteins induced by vitamin K absence 
(PIVKA-II), undercarboxylated serum osteocalcin, and urinary γ-carboxyglutamic 
acid excretion (Bach et al. 1996; Sokoll and Sadowski 1996; Shearer and Newman 
2008; Shearer et al. 2012). To the best of our knowledge, there have been no detailed 
investigations measuring vitamin K1 or K2 in combination with clotting time, 
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PIVKA-II, osteocalcin or other factors to systematically assess vitamin K status of 
captive or free-ranging wildlife. Such data might in fact help address the differential 
sensitivity of some non-target species (e.g., predatory birds) to ARs.
Dietary vitamin K is a significant factor in the management of oral anticoagu-
lant therapy in man (Holmes et al. 2012). However, from a pest management per-
spective, providing a diet of forage rich in vitamin K1 to various target rodents had 
little effect on the toxicity of various AR baits (Witmer and Burke 2009; Witmer 
et al. 2013). Based on the present review of AR toxicity studies in non-target wild-
life, vitamin K content of maintenance and/or exposure diets has been inconsis-
tent, and often unspecified. Some studies report that diet rations are supplemented 
with vitamin K in the form of menadione (i.e., vitamin K3, an inactive provitamin; 
Buitenhuis et al. 1990) (e.g., Rattner et al. 2014b, 2015), and others purposefully 
used vitamin K deficient diets (e.g., Greaves and Ayres 1973; Veltman et al. 1981; 
important note: vitamin K deficient diets are not necessarily devoid of vitamin K). 
While it might seem that inclusion of dietary menadione in AR studies is akin to 
administering antidote with the test compound, this may, or may not, be the case. 
Specifically, menadione is much less potent than vitamin K1 in restoring prothrom-
bin time following therapeutic anticoagulant administration in man (Hanson et al. 
1951) and in treating AR intoxication in dogs (Mount et al. 1986), and it does not 
reverse prolonged clotting time in chickens receiving coumarin-type ARs 
(Griminger 1965). The provitamin menadione must undergo enzymatic prenyl-
ation (rate limited) to form menaquinone-4 (MK-4, member of the K2 family) prior 
to VKOR metabolism to the biologically active form (i.e., vitamin K hydroqui-
none) required for γ-glutamyl vitamin K-dependent carboxylation (Hirota et  al. 
2013). Even if there are more than adequate quantities of menaquinone-4 and 
some other forms of vitamin K, they will not be optimally recycled if VKOR is 
inhibited by an AR. Furthermore, as described above, vitamin K deficient diets can 
result in prolonged blood clotting, and might actually exacerbate AR toxicity. In 
secondary exposure studies, the vitamin K status of AR-exposed prey fed to preda-
tors would seemingly be low. Clearly, vitamin K content of test diets should be 
carefully considered when designing AR toxicity studies, particularly those that 
examine toxicokinetics of recovery following termination of AR exposure (e.g., 
Rattner et al. 2014b).
9  Conclusion
Anticoagulant rodenticides continue to be one of the principal vertebrate pesticides 
used for the control of commensal rodents that damage crops and food stores, and 
cause health issues, and for the eradication of invasive species to restore biodiver-
sity to oceanic islands. Their use will likely continue into the foreseeable future. 
There remain some significant knowledge gaps and uncertainties that should be 
addressed to more completely assess AR risk to non-target wildlife. Despite the 
availability of extensive acute toxicity data to support ecological risk assessments, 
the breadth of species (laboratory rats, mice and rabbits, quail, mallards, 
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passerines) is limited, with data generally lacking for predatory and scavenging 
wildlife which have the greatest likelihood of exposure. Additional data on the 
risks associated with repeated exposure, exposure to multiple compounds, and sub-
lethal effects would be beneficial. Furthermore, it remains difficult to link body 
burdens with coagulopathy and other adverse effects. The effect of vitamin K sta-
tus on sensitivity to ARs deserves further attention, particularly in predatory and 
scavenging birds. While some of these critical data gaps would be best derived 
through whole animal research studies, others might be addressed by use of scaling 
and extrapolation factors (e.g., Mineau et al. 2001; Awkerman et al. 2008), alterna-
tive toxicology testing methods and in silico modeling methods (Committee on 
Toxicity Testing and Assessment of Environmental Agents 2007; Allen and Water 
2013). Obtaining more complete knowledge on the toxicity of ARs to wildlife 
would enable pesticide regulators and natural resource managers to better predict 
and even mitigate risk, particularly in forecasting effects in wildlife from the indi-
vidual though population levels.
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